Omega Therapeutics, Inc. (OMGA) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.40 per share a year ago.

Omega Therapeutics ( (OMGA) ) has shared an announcement.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall ...

Raymond James cut shares of Omega Therapeutics (NASDAQ:OMGA – Free Report) from an outperform rating to a market perform rating in a report issued on Friday morning, MarketBeat Ratings reports.

Old Mutual Global Equity earns an Average Process Pillar rating. The leading factor in the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its five-year ...

Short interest in Omega Therapeutics Inc (NASDAQ:OMGA) decreased during the last reporting period, falling from 5.67M to 5.47M. This put 28.24% of the company's publicly available shares short.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Investing.com - Omega Therapeutics (NASDAQ: OMGA) reported third quarter EPS of $-0.300, $0.02 worse than the analyst estimate of $-0.280. Revenue for the quarter came in at... ByInvesting.com ...